MA 05.02 STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共1页
• 作者

  F. Skoulidis; L. Albacker; M. Hellmann; M. Awad; J. Gainor; M. Goldberg; A. Schrock; L. Gay; J. Elvin; J. Ross; H. Rizvi; B. Carter; J. Erasmus; D. Halpenny; A. Plodkowski; N. Long; M. Nishino-Habatu; W. Denning; J. Rodriguez-Canales; P. Villalobos; E. Parra Cuentas; L. Sholl; J. Sauter; Y. Elamin; J. Zhang; G. Leonardi; K. Wong; P.J. Stephens; V. Papadimitrakopoulou; I. Wistuba; J. Wolchok; A. Shaw; P. J?nne; C. Rudin; V. Miller; J. Heymach;

  展开▼
• 作者单位

  Thoracic Head &

  Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;

  Foundation Medicine Inc;

  Memorial Sloan Kettering Cancer Center;

  Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute;

  Massachusetts General Hospital;

  Foundation Medicine Inc;

  Foundation Medicine;

  Foundation Medicine;

  Foundation Medicine;

  Pathology Foundation Medicine;

  Memorial Sloan Kettering Cancer Center;

  Thoracic Imaging The University of Texas MD Anderson Cancer Center;

  Thoracic Imaging The University of Texas MD Anderson Cancer Center;

  Memorial Sloan Kettering Cancer Center;

  Memorial Sloan Kettering Cancer Center;

  Memorial Sloan Kettering Cancer Center;

  Radiology Dana-Farber Cancer Institute and Brigham and Women’s Hospital;

  Thoracic Head &

  Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;

  Translational Molecular Pathology MD Anderson;

  Translational Molecular Pathology MD Anderson;

  Translational Molecular Pathology MD Anderson;

  Brigham and Women’s Hospital;

  Memorial Sloan Kettering Cancer Center;

  Thoracic Head &

  Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;

  Thoracic Head &

  Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;

  Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute;

  Division of Hematology Oncology New York University Langone Medical Center;

  Foundation Medicine Inc. Cambridge;

  Thoracic Head &

  Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;

  4Translational Molecular Pathology The University of Texas MD Anderson Cancer Center;

  Memorial Sloan Kettering Cancer Center;

  Thoracic Oncology Massachusetts General Hospital Harvard Medical School;

  Dana-Farber Cancer Institute;

  Thoracic Oncology Memorial Sloan Kettering Cancer Center;

  Clinical Development Foundation Medicine Inc;

  Thoracic Head &

  Neck Medical Oncology The University of Texas M. D. Anderson Cancer Center;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词